Company intelligence / Profile preview

CeaLogic

Ownership: Private
Development stage: Commercial

Overview

Recibio markets the CeaLogic line of medical devices, including an amniotic perforator for safe membrane puncture during childbirth, a specimen collection kit with a unique design for easy sample handling, and a ratio applicator kit for simultaneous delivery of two liquids in surgery. These products are commercially available and designed to improve safety and efficiency in clinical procedures[1].

Therapeutic areas: OtherInfectious DiseasesWomen's Health
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on CeaLogic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CeaLogic.

Explore the full profile